SCHEMBL24318644

SCHEMBL24318644

Brc1cc(-c2cccnc2)c(-c2cccnc2)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 11/20 0.50
CYP3A4 P08684 6/20 0.47
ALDH1A1 P00352 2/20 0.47
CYP1A2 P05177 1/20 0.47
PTPN1 P18031 1/20 0.45
CYP2C9 P11712 5/20 0.44
CYP2E1 P05181 4/20 0.44
CYP2B6 P20813 4/20 0.44
CYP2C19 P33261 4/20 0.44
CYP2D6 P10635 3/20 0.44
CYP11B1 P15538 2/20 0.44
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22300075 0.93 ALOX5 (0.44) CYP2A6CYP3A4ALDH1A1CYP1A2PTPN1
SCHEMBL1425328 0.81 CYP2A6 (0.54) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2C9
SCHEMBL24319540 0.74 MAPK14 (0.51) CYP3A4CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL22299320 0.74 PTGS1 (0.49) CYP3A4ALDH1A1CYP1A2PTPN1CYP2C9
SCHEMBL16694670 0.72 CYP2A6 (0.70) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2C9
SCHEMBL30187061 0.72 CYP2A6 (0.70) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2C9
SCHEMBL12402387 0.71 CYP2A6 (0.61) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2C9
SCHEMBL12195715 0.70 CYP2A6 (0.57) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2C9
SCHEMBL24318549 0.69 CYP2A6 (0.66) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2C9
SCHEMBL255577 0.69 KDM4E (0.66) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220098217-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE LT MATERIALS CO., LTD. (KR) 2022-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220098217-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE AOX1, OXER1, OR51E2 CYP2A6 450/4885CYP3A4 278/4885ALDH1A1 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.